Skip to main content
. 2014 Jul 9;5(15):6289–6299. doi: 10.18632/oncotarget.2198

Figure 4. Effect of pAKT on cPLA2α is independent of ERK1/2.

Figure 4

(a) LNCaP cells stably transfected with Dox-controlled inducible cPLA2α expression system (LNCaP-i-cPLA2α) were treated with Dox (100 ng/mL, 24 h), followed by incubation with MEK inhibitor U0126 (5 μM, 1 h). The cells were harvested 24 h later. (b) LNCaP-i-cPLA2α cells induced with Dox for 1 h and transfected with Myr-AKT or empty vector (2 μg, 24 h), followed by incubation with U0126 (5 μM, 1 h). The cells were harvested 24 h later. All immunoblotting results are typical of 3 independent experiments.